Science ❯ Biotechnology

Clinical Trials

Psychedelic Research Antibodies Nasal COVID-19 Vaccine Gene Mutation Medical Research Cancer Immunotherapy Safety Testing Trial Design Human Trials Cancer Research

Gilead to Buy Ouro Medicines as Galapagos Enters Talks to Share Costs

The potential pact would spread financial risk while advancing a novel T cell therapy for autoimmune disease.

Viking Therapeutics Pushes VK2735 Through Pivotal Trials as Next Enrollment Milestone Nears

Mirum to Acquire Bluejay Therapeutics in Up to $820 Million Deal for Hepatitis D Drug

Sarepta Shares Plunge After ESSENCE Phase 3 Miss in Duchenne Trial

FDA Setback Puts uniQure’s Huntington’s Gene Therapy Filing in Doubt

First Human Trial Finds Enteral Ventilation Procedure Tolerable in Healthy Volunteers

Samsung Invests $110 Million in Grail to Bring Galleri Cancer Test to Asia

AbbVie Agrees to Buy Gilgamesh’s Bretisilocin for Up to $1.2 Billion

BioNTech Halves Q2 Loss as mRNA Cancer Pipeline Advances

YCT-529 Pill Proves Safe in Phase 1 Trial, Set for Efficacy Testing

FDA Rejects Replimune’s RP1 Melanoma Immunotherapy

Adam Male Contraceptive Implant Shows Two-Year Efficacy in Phase 1 Trials

BioNTech Acquires China's Biotheus for $800 Million to Enhance Cancer Drug Development

Oxford Researchers Develop Promising Ovarian Cancer Vaccine

CRISPR Gene Therapy Shows Promising Results in Treating Inherited Blindness